Form 4: Vicarious Surgical CEO Adam Sachs Sells Shares to Cover Tax Obligations
SEC Form 4
Vicarious Surgical CEO Adam Sachs sold 535 shares of Class A Common Stock on March 3, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 3, 2025, Adam David Sachs, CEO of Vicarious Surgical Inc., sold 535 shares of Class A Common Stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on June 2, 2023.
- The shares were sold at a weighted average price of $10.2791, with individual trades ranging from $9.40 to $11.00 per share.
- Following the transaction, Sachs directly owns 52,164 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: Neutral. This is a standard transaction for covering tax obligations and doesn't reflect a significant change in sentiment.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It doesn't necessarily indicate a change in the company's prospects or management's confidence.
Stakeholder Impact
- The sale of shares could have a minor, temporary impact on the stock price, but it's unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 06/02/2023 | Date of grant for the restricted stock units. |
| 03/03/2025 | Date of the stock sale transaction. |
| 03/04/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.